Skip to main content
AMEAMETEK, Inc.Hold5.5·$234.62-1.06%
HoldModerate Confidence
Investment thesis

AMETEK operates a high-quality industrial franchise with a wide economic moat, 20% operating margins, and a perfect four-quarter earnings beat streak averaging nearly 5% above estimates; the concern is not the business but the price — at a forward multiple of 26.2 times and a PEG near 3.0, with the stock just 1.2% below the analyst consensus target, the risk/reward is thin and the position warrants a trim.

Thesis pillars

  • Wide Moat Margin QualityStable
  • Rich Valuation Limits EntryStable
  • Consistent Earnings Beat ExecutionStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

AMETEK, Inc. (AME) Stock Analysis

Breakout setup · Catalyst-Driven edge

HoldModerate Confidence

Industrials · Specialty Industrial Machinery

Hold if already holding. Not a fresh buy at $234.62, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (4.1% away).

AMETEK manufactures electronic instruments (EIG segment: process, power, aerospace analytical gear) and electromechanical devices (EMG segment: precision motion, medical components, specialty metals) globally. The company posted $7,401.1 million in sales in 2025, selling through... Read more

$234.62+10.5% A.UpsideScore 5.5/10#24 of 58 Specialty Industrial Machinery
QualityF-score8 / 9FCF yield2.58%
IncomeYield0.58%(5y avg 0.62%)Payout19.18%sustainable
Entry $213.51(200-day MA)Stop $201.61Target $235.85(analyst − 10%)A.R:R 0.1:1
Analyst target$262.05+11.7%19 analysts
$235.85our TP
$234.62price
$262.05mean
$217
$303

Hold if already holding. Not a fresh buy at $234.62, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (4.1% away). Chart setup: Golden cross, above all MAs, RSI 59, MACD bullish. Downgraded from BUY WAIT — price $234.62 has reached target $235.85. No upside to wait for. Score 5.5/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, news boost analyst 0.50, earnings proximity 26d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

10-K grounded · weekly refresh

About AMETEK, Inc.

About AMETEK, Inc.

AMETEK's two operating groups generated $7,401.1 million in net sales in 2025, a 6.6% increase over 2024. EIG split 70% process/analytical instrumentation and 30% aerospace/power, while EMG divided 70% automation/engineered solutions and 30% aerospace. The company employed approximately 22,200 people—12,800 in EIG, 9,400 in EMG—across manufacturing facilities in 22 countries, with international sales reaching 48.2% of consolidated net sales.

AMETEK earns revenue by selling highly differentiated instruments and components to industrial, aerospace/defense, medical, and process OEM customers. EIG supplies analytical and test/measurement instruments to pharmaceutical, semiconductor, food/beverage, oil/gas, and power generation industries, and delivers airborne data systems, turbine sensors, and embedded computing to commercial and military aerospace. EMG provides single-use and consumable surgical instruments, precision motion control solutions, specialty metals, and thermal management systems, and operates a global aviation MRO network across facilities in the United States, Europe, and Asia. Distribution is primarily through direct sales forces for technically sophisticated products, supplemented by distributors and specialized representatives. AMETEK completed two acquisitions in 2025 for a combined $933.2 million—Kern Microtechnik in January for high-precision machining, and FARO Technologies in July for 3D measurement and imaging. No EIG customer exceeds 2% of EIG net sales; no EMG customer exceeds 5%.

Show full overview

The 10-K discloses that certain raw materials, including base metals and steel components available from only a limited number of suppliers, are subject to commodity price fluctuations that could weigh on margins. Several end markets—aerospace/defense, oil/gas, and process instrumentation—are explicitly flagged as cyclical, with demand tied to customers' capital spending budgets and government funding policies. AMETEK's 70-plus-year track record as an established aerospace supplier and long-standing relationships with aircraft and jet engine OEMs provide some buffer against cycle swings, but the filing notes visibility is limited particularly for markets served through distribution.

See also: Industrials · Specialty Industrial Machinery

From AMETEK, Inc.'s most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-06

Recent Developments — AMETEK, Inc.

Generated 2026-07-06T05:40:26Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Jul 30, 202626d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
Positive news sentiment (+1.00)
Wide economic moat
Risks
Analyst target reached - limited upside remaining
Near 52-week high (4.1% away)
Expensive valuation

Key Metrics

P/E (TTM)35.4
P/E (Fwd)26.7
Mkt Cap$53.8B
EV/EBITDA23.0
Profit Mgn20.1%
ROE14.6%
Rev Growth11.3%
Beta0.99
Dividend0.58%
Rating analysts25

Quality Signals

Piotroski F8/9MoatWideCompounder

Options Flow

P/C1.75bearish
IV48%normal

Concentration Risks(10-K Item 1A)

  • LOWCustomerEMG five largest customers15%
    10-K Item 1: 'Approximately 15% of EMG's 2025 net sales were made to its five largest customers. No single customer comprises greater than 5% of net sales.'

Material Events(8-K, last 90d)

  • 2026-05-08Item 5.02LOW
    Nick L. Stanage appointed to AMETEK Board of Directors as Class III independent director effective May 7, 2026, serving until 2027 Annual Meeting. No arrangement with any other person cited. Successor to no departing director named.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Pe
3.6
Peg Ratio
3.7
Forward Pe
4.7
Analyst Target
5.0
Ps
5.5
Forward P/E: 26.7xPEG: 3.04
GatesA.R:R 0.1 < 1.5@spotExecutive change: officer departure/appointmentMomentum 5.5>=5.5Insider activity: OKNEWS BOOST ANALYST 0.50EARNINGS PROXIMITY 26d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
59 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $220.66Resistance $244.71

Price Targets

$202
$214
$236
A.Upside+0.5%
A.R:R0.1:1

Position Sizing

ConvictionMedium conviction
Suggested %0.8%
Max %1.7%
RegimeSteady

Risk Alerts

! Target reached (0.5% upside)
! NEWS_MOD=+2: HOLD_IF_HOLDING → STRONG_BUY_WAIT
! asymmetry at 0.1 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-30 (26d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AME stock a buy right now?

Hold if already holding. Not a fresh buy at $234.62, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (4.1% away). Chart setup: Golden cross, above all MAs, RSI 59, MACD bullish. Downgraded from BUY WAIT — price $234.62 has reached target $235.85. No upside to wait for. Target $235.85 (+0.5%), stop $201.61 (−16.4%), A.R:R 0.1:1. Score 5.5/10, moderate confidence.

What is the AME stock price target?

Take-profit target: $235.85 (+10.5% upside). Target $235.85 (+0.5%), stop $201.61 (−16.4%), A.R:R 0.1:1. Stop-loss: $201.61.

What are the risks of investing in AME?

Analyst target reached - limited upside remaining; Near 52-week high (4.1% away); Expensive valuation.

Is AME overvalued or undervalued?

AMETEK, Inc. trades at a P/E of 35.4 (forward 26.7). TrendMatrix value score: 3.9/10. Verdict: Hold.

What do analysts say about AME?

25 analysts cover AME with a consensus score of 3.8/5. Average price target: $262.

What does AMETEK, Inc. do?AMETEK manufactures electronic instruments (EIG segment: process, power, aerospace analytical gear) and...

AMETEK manufactures electronic instruments (EIG segment: process, power, aerospace analytical gear) and electromechanical devices (EMG segment: precision motion, medical components, specialty metals) globally. The company posted $7,401.1 million in sales in 2025, selling through direct sales forces and distributors to industrial, aerospace, and medical OEM customers.

Related stocks: MIDD (The Middleby Corporation) · WTS (Watts Water Technologies, Inc.) · OTIS (Otis Worldwide Corporation) · JBTM (JBT Marel Corporation) · DCI (Donaldson Company, Inc.)
Home Stocks AME

Latest news

Latest News

StockStory68d agoEarnings
TradingView68d agoEarnings
The Motley Fool74d agoEarnings
GuruFocus75d ago
MarketBeat75d ago
Seeking Alpha61d agoMerger Acquisition
Ad-hoc-news.de5d ago
Seeking Alpha5d agoMerger Acquisition
GuruFocus5d ago
GuruFocus6d agoAnalyst
Ad-hoc-news.de6d ago
The Globe and Mail62d ago
MarketBeat62d ago
The Globe and Mail62d agoAnalyst
Simplywall.st62d ago
MSN66d agoEarnings
Investing.com Australia11d ago
Investing.com11d ago
Yahoo Finance74d agoEarnings
MarketBeat74d ago
Loading more...